Thereby, BPC 157 is effective in wound healing much like it is effective in counteracting bleeding disorders, produced by amputation, and/or anticoagulants application
Retatrutide, a triple agonist (GLP-1, GIP, glucagon receptor), showed roughly 24% weight loss at 48 weeks in phase 2 trials (Jastreboff 2023, NEJM )
[Google Scholar] [PubMed] [CrossRef] 69
For those with ME/CFS, autoimmune disorders, and degenerative neurological diseases like Parkinsons and Alzheimers, I advise aiming for no less than 500 pg/mL, with an optimal of at least 750 pg/mL
GLP-1 medications mimic the structure and function of your body's native GLP-1, amplifying these appetite-suppressing and metabolic signals
Meanwhile, the concentration of its three constituent amino acids: glutamate, glycine, and cysteine was 268 M (21.97%), 477 M (39.10%), and 264.7 M (21.70%), respectively.[] ADVERSE EFFECTS OF IV GLUTATHIONE Intravenous doses have been known to show more adverse effects due to the chances of overdose or due to the additives which are present in glutathione injection